Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Frazer

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|May 12, 2010
Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosisYifeng Xiong, Bradley R Teegarden, Jin-Sun Karoline Choi, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2011
Identification of biaryl sulfone derivatives as antagonists of the histamine H₃ receptor: discovery of (R)-1-(2-(4'-(3-methoxypropylsulfonyl)biphenyl-4-yl)ethyl)-2-methylpyrrolidine (APD916)Graeme Semple, Vincent J Santora, Jeffrey M Smith, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2008
A new family of H3 receptor antagonists based on the natural product ConessineVincent J Santora, Jonathan A Covel, Rena Hayashi, et al.
Journal of Medicinal Chemistry|September 3, 2009
Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activityJonathan A Covel, Vincent J Santora, Jeffrey M Smith, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|May 12, 2010
Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosisYifeng Xiong, Bradley R Teegarden, Jin-Sun Karoline Choi, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2011
Identification of biaryl sulfone derivatives as antagonists of the histamine H₃ receptor: discovery of (R)-1-(2-(4'-(3-methoxypropylsulfonyl)biphenyl-4-yl)ethyl)-2-methylpyrrolidine (APD916)Graeme Semple, Vincent J Santora, Jeffrey M Smith, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2008
A new family of H3 receptor antagonists based on the natural product ConessineVincent J Santora, Jonathan A Covel, Rena Hayashi, et al.
Journal of Medicinal Chemistry|September 3, 2009
Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activityJonathan A Covel, Vincent J Santora, Jeffrey M Smith, et al.
Pageof 2